PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising advancements throughout a variety of health-related and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA delivers a safer, additional trusted alternate for